Skeletal health in men with chronic lung disease: Rates of testing, treatment, and fractures

Osteoporosis International

Volumn 22, Issue 6, 2011, Pages 1855-1862

  Morden, N E ^a,b,c   Sullivan, S D ^d   Bartle, B ^e   Lee, T A ^f  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c White River Junction VT ^*  (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f HINES VA HOSPITAL   (United States)

Author keywords

Osteoporosis; Prevention; Pulmonary disease

Indexed keywords

ALENDRONIC ACID; ANTIPARKINSON AGENT; BARBITURIC ACID DERIVATIVE; CALCITONIN; CORTICOSTEROID; ETIDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; BONE DENSITOMETRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE EXACERBATION; ETHNICITY; FOLLOW UP; FRAGILITY FRACTURE; GROUPS BY AGE; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WRIST FRACTURE;

AGE DISTRIBUTION; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG UTILIZATION; HIP FRACTURES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEW HAMPSHIRE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; WRIST INJURIES;

EID: 79959978501     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1423-y     Document Type: Conference Paper

References (40)

1. Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Riskadjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17(7):514-519 (Pubitemid 46950928)
2. Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51(3):364-370 (Pubitemid 36348898)
3. Haentjens P, Lamraski G, Boonen S (2005) Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil 27(18-19):1129-1141 (Pubitemid 41699885)
4. Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15(11):897-902 (Pubitemid 39506456)
5. Khasraghi FA, Lee EJ, Christmas C, Wenz JF (2003) The economic impact of medical complications in geriatric patients with hip fracture. Orthopedics 26(1):49-53, discussion 53 (Pubitemid 36395058)
6. Biskobing DM (2002) COPD and osteoporosis. Chest 121(2):609-620 (Pubitemid 34133004)
7. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS (1999) Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 116(6):1616-1624 (Pubitemid 30012703)
8. Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E (2009) Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int 21:1341-1349
9. Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132(5):1599-1607 (Pubitemid 350156018)
10. Sin DD, Man JP, Man SF (2003) The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114(1):10-14 (Pubitemid 36126509)
11. Lekamwasam S, Trivedi DP, Khaw KT (2005) An association between respiratory function and hip bone mineral density in older men: a cross-sectional study. Osteoporos Int 16(2):204-207 (Pubitemid 40193209)
12. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V (2007) The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101(1):177-185 (Pubitemid 44835231)
13. Shane E, Silverberg SJ, Donovan D et al (1996) Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 101(3):262-269 (Pubitemid 26392439)
14. Papaioannou A, Parkinson W, Ferko N et al (2003) Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14(11):913-917 (Pubitemid 38009531)
15. Li L, Brennan KJ, Gaughan JP, Ciccolella DE, Kuzma AM, Criner GJ (2008) African Americans and men with severe COPD have a high prevalence of osteoporosis. COPD 5(5):291-297
16. Barr RG, Celli BR, Mannino DM et al (2009) Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 122(4):348-355
17. Franco CB, Paz-Filho G, Gomes PE et al (2009) Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 20:1881-1887
18. Carter JD, Patel S, Sultan FL et al (2008) The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med 102(8):1165-1172
19. Penrod JD, Litke A, Hawkes WG et al (2008) The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci 63(8):867-872
20. Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 18(12):1583-1593 (Pubitemid 47620310)
21. de Luise C, Brimacombe M, Pedersen L, Sorensen HT (2008) Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol 23(2):115-122
22. Leech JA, Dulberg C, Kellie S, Pattee L, Gay J (1990) Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 141(1):68-71 (Pubitemid 20023384)
23. McKnight J, Scott A, Menzies D, Bourbeau J, Blais L, Lemiere C (2005) A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 58(2):206-208 (Pubitemid 40174931)
24. Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG (2009) Identification and validation of vertebral compression fractures using administrative claims data. Med Care 47(1):69-72
25. Curtis JR, Taylor AJ, Matthews RS et al (2009) "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporos Int 20:1969-1972
26. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV (2009) New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 44(5 Pt 1):1640-1661
27. Sawka AM, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L (2005) Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of antifracture efficacy in women. BMC Musculoskelet Disord 6:39
28. Nelson HD, Helfand M, Woolf SH, Allan JD (2002) Screening for postmenopausal osteoporosis: a review of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 137(6):529-541 (Pubitemid 35024625)
29. Hansen KE, Swenson ED, Baltz B, Schuna AA, Jones AN, Elliott ME (2008) Adherence to alendronate in male veterans. Osteoporos Int 19(3):349-356 (Pubitemid 351199186)
30. Melton LJ 3rd, Crowson CS, O'Fallon WM (1999) Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9(1):29-37 (Pubitemid 29086162)
31. Ettinger B, Black D, Dawson-Hughes B, Pressman A, Melton JL (2010) Updated fracture incidence rates for US version of FRAX. Osteoporos Int 21:25-33
32. Jorgensen NR, Schwarz P (2008) Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 14(2):122-127 (Pubitemid 351323163)
33. Daniell HW (1972) Osteoporosis and smoking. JAMA 221(5):509
34. Lewiecki EM, Gordon CM, Baim S et al (2008) International society for clinical densitometry 2007 adult and pediatric official positions. Bone 43(6):1115-1121
35. Lim LS, Hoeksema LJ, Sherin K (2009) Screening for osteoporosis in the adult U. S. population: ACPM position statement on preventive practice. Am J Prev Med 36(4):366-375
36. National Osteoporosis Foundation (2008) The clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/ clinicians-guide.htm. Accessed June 17, 2009
37. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK (2008) Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148(9):680-684 (Pubitemid 351669113)
38. Affairs VDCPGUSDoV (2007) Management of Chronic Obstructive Pulmonary Disease (COPD). http://www.healthquality.va.gov/Chronic-Obstructive-Pulmonary- Disease-COPD.asp. Accessed August 27, 2010
39. Piette JD, Heisler M (2004) Problems due to medication costs among VA and non-VA patients with chronic illnesses. Am J Manage Care 10(11 Pt 2):861-868
40. Department of Veterans Affairs (2010) Federal benefits for veterans, dependents & survivors. http://www1.va.gov/opa/publications/benefits-book/ federal-benefits.pdf Accessed August 26